.jpg?format=webp&width=780)
The article discusses how pneumonia survivors experience an accelerated health decline with an increased risk of cardiovascular disease due to a persistent dysregulated inflammatory response post-pneumonia. The unregulated inflammatory response exacerbates atherosclerotic vascular disease, leading to adverse cardiac events such as myocardial infarction. The review proposes the need to better understand the inflammatory cross talk between the lungs and the heart during and after pneumonia to develop therapeutics that prevent pneumonia-associated cardiovascular events. The article suggests leveraging strategies to promote inflammatory resolution pathways as a novel therapeutic target to reduce the risk of cardiac events post-pneumonia.
Like
Save
Share